Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
92 Construction and validation of alternative biomarker immunohistochemistry assays on the path to companion diagnostics
- 12CellCarta, Antwerp, Belgium
- 2CellCarta, Antwerp, Belgium
Related
- High-Throughput Proteomics in Lymphangioleiomyomatosis: Premelanosome Protein as a Diagnostic Biomarker, Construction of a Diagnosis Score, and Evidence of Neutrophil Involvement
- Transcriptomic Profiling Reveals METTL26 as a Potential Biomarker in Head and Neck Squamous Cell Carcinoma with Independent Validation in Oral Squamous Cell Carcinoma
- A clinicopathological and hematological biomarker-based nomogram for overall survival in early-onset colorectal cancer: development, external validation, and translational implications
- Identification and validation of serum EPHB2 as a candidate biomarker for colorectal cancer and precancerous lesions
- Construction and validation of a nomogram prediction model for the risk of delirium after hip arthroplasty in elderly patients
BibTeX
@article{giacomazzi2026construction,
title = {{92 Construction and validation of alternative biomarker immunohistochemistry assays on the path to companion diagnostics}},
author = {Giorgia Giacomazzi and Elizabeth L Ross and Roos Van Elzen and Charlotte Rypens and Sandra Vandevelde and Acknowledgements Dieter Peeters},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0092},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0092},
note = {CC BY},
}
RIS
TY - JOUR
TI - 92 Construction and validation of alternative biomarker immunohistochemistry assays on the path to companion diagnostics
AU - Giorgia Giacomazzi
AU - Elizabeth L Ross
AU - Roos Van Elzen
AU - Charlotte Rypens
AU - Sandra Vandevelde
AU - Acknowledgements Dieter Peeters
PY - 2026
DA - 2026/11/06
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0092
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0092
SN - 2051-1426
ER -